Please note that the Open Session for this meeting will be on Monday, April 30 from
4-5pm and Tuesday, May 1, rather than the usual time on Monday.
This meeting will be in Closed Session from 9:45 am- 4:00 pm on Monday, April 30.
Monday, April 30
Time
Activity
Speaker
9:30 – 9:45
Welcome – Opening Remarks
Dr. Muin Khoury
Dr. Kathleen Toomey
9:45 – 10:00
Closed Session called to order
Al Berg, Chair
10:00 – 12:15
Ongoing and new evidence review planning
WG Members, Staff & Consultants
12:15 – 1:15
Lunch
Discussion: Review of Genetic Tests
Dr. Bob Becker, FDA
1:15 – 3:00
Working Group discussion of Draft Recommendations
WG Members
3:00 – 3:15
Break
3:15 – 4:00
Continuing Working Group discussion Closed session adjourned
4:00 – 4:30
Open Session called to order
Report on Planning Meeting for Stakeholder Group (SAGE)
Linda Bradley
Toby Citrin
4:30 – 5:00
Wrap-up and Adjourn Closed Session
Al Berg, Chair
Tuesday, May 1
Time
Activity
Speaker
8:00 – 9:00
Executive Session – Working Group Members only
Al Berg
The meeting will be Open Session from 9:00am to 2:00pm on Tuesday, May 1
9:00 – 9:30
Open session called to order
Overview of Day 1 and outstanding questions
Al Berg, Chair & Staff
9:30 – 10:00
Staff Updates on EGAPP Activities
Linda Bradley &
Michael Douglas
10:15 – 10:45
Break
10:45 – 11:30
Products Subcommittee Report
Celia Kaye
11:30 – 12:15
Topics Subcommittee Report
Joan Scott
12:15 – 1:00
Working Lunch
Updates on other Evidence-based Groups
Outstanding issues
Steve Teutsch
1:00 – 1:45
Methods Subcommittee Report
Steve Teutsch
1:45 – 2:00
Wrap-up and Action Items
Al Berg, Chair
Linda Bradley
2:00
Adjourn Open Session
Al Berg, Chair
Page last reviewed: October 12, 2013 (archived document)
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.